Objectives: The aim of this study was to describe the rates of antimicrobial susceptibility of Staphylococcus aureus from skin and wound infections reported from nine regions of the USA during 2005 -07 and to identify the regional variation in patterns of resistance.
Introduction
Staphylococcus aureus has recently gained significant notoriety in both the medical and lay press and media principally through an apparent increase in the proportion of fatal infections, notably among children. The awareness of physicians and public alike has been elevated, and changes in clinical practice may be driven by panic and concern. The increase in strains of S. aureus producing Panton -Valentine leucocidin (PVL) seems most apparent in community-acquired infections, although little longitudinal data exist to support this perception. Nevertheless, PVL-positive methicillin-resistant S. aureus (MRSA) are an increasing cause of infections, a number of which have rapidly progressed to hospitalization or fatality. 1 -3 This article presents data from a large-scale laboratory-based surveillance programme over the period 2005 -07 from almost 300 hospitals across the USA.
Methods
The Surveillance Network (TSN w ) was the data source for this investigation. It comprises an electronic database of strain-specific, qualitative and quantitative antimicrobial susceptibility test data reported by clinical laboratories in the USA that has been previously used to evaluate trends concerning antimicrobial susceptibility. 4 -6 The TSN database contains over 120 million susceptibility results collected from 296 US institutions. Susceptibility was determined according to CLSI breakpoints that were current in the year of testing. 7 -9 Besides in vitro susceptibility data, TSN gathers profiles from other queries that can be used individually or in any combination for the analysis of susceptibility data including organism identification, national and regional geography, such as the nine regions of the US Bureau of Census, institution demographics (type and number of beds), patient demographics (age, gender and location) and specimen source.
This analysis focused specifically on S. aureus and used TSN to investigate S. aureus isolated from January 2005 to September 2007. The overall prevalence of S. aureus isolates taken from skin and wound specimen sources was studied according to patient location including inpatient, intensive care unit (ICU) and outpatient. Strains of S. aureus isolated from skin or wound infections were used as the source most likely to yield the highest incidence of this species as per Styers et al.
10 MRSA rates for the study period were estimated by year. In addition, S. aureus and MRSA specifically were analysed by US Bureau of Census region. Susceptibility to erythromycin, trimethoprim/sulfamethoxazole and levofloxacin were examined as well as multidrug-resistant (MDR), defined as concurrent resistance to three or more of the following agents: ciprofloxacin, clindamycin, erythromycin, gentamicin, oxacillin and trimethoprim/ sulfamethoxazole. Only strains tested simultaneously against each of these agents were included in the MDR analysis of prevalence and distribution of resistance. All incidence rates were compared statistically using x 2 analysis, with a P value of less than 0.05 being significant.
Results
The rate of resistance among S. aureus over the period 2005 -07 is shown in Table 2 ).
The regional differences in resistance among S. aureus in 2007 are shown in Figure 1 . The lowest rate of MRSA was observed in the New England region (48.1%) and in the Mid-Atlantic region (48.9%), compared with the highest rates observed in the East South Central region (67.3%) and in the West South Central region (67.0%); these differences were statistically significant (P , 0.05). The West South Central region also showed the highest erythromycin resistance rate (72.3%), when compared with New England, which retained the lowest resistance rate of 56.8% (P , 0.05). Levofloxacin, as a representative of the fluoroquinolones used to treat skin infections when compared with other oral antibiotics, showed a lower overall resistance rate of 39.5% in 2007, but still regional differences were reported, with New England showing the lowest resistance rate of 23.4% when compared with the Mountain region showing a statistically significantly higher resistance rate of 52.4%. Of note, the lowest resistance rates were seen with trimethoprim/sulfamethoxazole (for which the rates ranged from 0.7% in West North Central and East South Central to 3.7% in East North Central) and vancomycin, for which no resistance was detected. Linezolid resistance was reported in 13 of 80 527 isolates in 2007 (Table 1) , although these have not been confirmed. Although increasingly used to manage superficial skin infections, mupirocin was not tested in any laboratory. Thus, we are unable to comment on resistance emergence to this agent.
Among MDR isolates, the most commonly observed resistances were to erythromycin (99.4%), oxacillin (95.1%) and ciprofloxacin (95.6%), whereas resistance to gentamicin and trimethoprim/sulfamethoxazole was seen in 5.7% and 3.9% of the MDR isolates, respectively ( Table 3 ). The analysis of the database by patient age showed that the proportion of S. aureus isolates that were MRSA was approximately the same in those aged 16 years and the elderly (65 years) (52.5% versus 51.3%, respectively, P ¼ 0.2), whereas the rate seen among those aged 17-64 years was significantly higher (56.5%; P , 0.01) compared with both the paediatric and elderly populations (Table 4) . Another interesting observation was the significantly lower proportion of S. aureus strains resistant to ciprofloxacin in patients aged 16 years (19.4%) when compared with isolates from patients aged 17-64 (34.7%) or 65 years (49.2%) (P , 0.01 for both comparisons). A similar trend was also noted with clindamycin with resistance seen in 8.9%, 15.7% and 33.8% of the isolates for the three respective cohorts (P , 0.01 for 16 year group compared with both 17-64 year and 65 year cohorts). In 2007, less than a third (30.3%) of all strains of S. aureus were pan-susceptible, whereas 11.6% expressed a single resistance phenotype (Table 5) . MDR was noted in 32% of the isolates. The distribution of these phenotypes by patient location among skin or wound infections is shown in Table 6 . Generally, the isolates from outpatient specimens were more susceptible than either inpatient or ICU sources. More strains carried two resistance mechanisms in the outpatient cohort,~30% compared with~10% among the ICU strains. Strains having four or more resistance mechanisms were seen more often in the ICU and inpatient strains than community S. aureus.
Discussion
Despite the current publicity surrounding MRSA, the overall rate of methicillin (oxacillin) resistance did not alter markedly in the 3 year study period, with almost two-thirds of all S. aureus, the most common cause of skin infections, being resistant to methicillin and macrolides. Concurrently, resistance to levofloxacin and other fluoroquinolones exceeded 20%, a threshold previously considered by the Infectious Disease Society of America to be suggestive of likely poorer outcomes.
However, what is not clear from this surveillance is the incidence of PVL-positive S. aureus, regardless of methicillin resistance. Although there is controversy over the exact role of PVL in serious staphylococcal disease, it still serves as a good marker of potentially difficult-to-treat staphylococcal infections based on the many reports of rapidly fulminant infections.
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One clear trend observed was the inter-regional difference in staphylococcal resistance; the New England and Mid-Atlantic regions generally had the lowest resistance rates, whereas the Central regions usually showed higher resistance rates. Other interesting differences included the higher incidence of MDR phenotypes in both inpatient and ICU isolates when compared with outpatient strains and the lack of age difference in terms of methicillin resistance, although both 
Susceptibility of S. aureus in the USA
clindamycin and ciprofloxacin resistances were lower in isolates from those aged 16 years. This latter difference may be due to less drug exposure as children are rarely treated with fluoroquinolones. Ellingson et al. 12 recently reported management approaches of skin infections in the USA where 13.3% of the patients had incision and drainage, whereas only 7% of the patients with skin infections had a culture performed with 4% having both incision and drainage and culture. Overall, almost .75% had neither incision and drainage nor culture performed. Recent analysis of over 50 million US patient visits due to skin infections requiring an antibiotic highlighted the continued use of cefalexin and other b-lactams as initial empirical therapy with topical agents only being used for impetigo or furuncles. There was very little use of agents such as trimethoprim/sulfamethoxazole or doxycycline. 13 Thus, on the basis of these habits and trends, the local application of TSN data may help improve the management of these infections most recently highlighted in both medical and lay media. However, only prospective and more expansive surveillance including isolates from infections not previously examined, such as impetigo, minor abrasions, or simple wounds, will continue to guide empirical management and therapy. In addition, testing of a sample of these strains for virulence factors will also assist in the education of both primary care and hospital health providers as MRSA from the community seemingly merges with the more antibiotic-resistant hospitalacquired strains. 
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